8-K: inTEST Corp Reports 4% Revenue Growth in Q2 2024, Acquisition Offsets Semiconductor Weakness

inTEST Corporation announced a 4% year-over-year revenue increase for the second quarter of 2024, driven by the acquisition of Alfamation, which helped offset a significant decline in the semiconductor market.

Summary

• inTEST Corporation reported a 4% increase in revenue year-over-year for the second quarter of 2024, reaching $34.0 million.
• This growth was primarily driven by the acquisition of Alfamation, which contributed $9.7 million in revenue.
• The company experienced a 46% year-over-year decline in semiconductor market sales, amounting to a decrease of $8.7 million.
• Orders improved 15% sequentially to $26.2 million, with a 10% sequential improvement excluding Alfamation.
• Earnings per diluted share were $0.02, while adjusted earnings per diluted share were $0.08.
• The company is implementing cost-cutting measures expected to yield $1.2 million in annualized savings starting in the third quarter.
• The company has adjusted its 2024 revenue guidance to $128 million to $133 million, down from the previous $140 million to $150 million.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant decline in semiconductor sales, reduced profitability, and lowered guidance, despite the positive impact of the Alfamation acquisition and cost-cutting measures.

Positives

• The acquisition of Alfamation significantly boosted revenue and offset the decline in the semiconductor market.
• The company's market diversification strategy is proving effective in mitigating the impact of the semiconductor downturn.
• Cost reduction initiatives are expected to improve profitability in the second half of the year.
• The company has extended the maturity of its debt facilities to May 2, 2031, providing financial stability.
• The company saw a 14% sequential increase in revenue.

Negatives

• The semiconductor market experienced a significant downturn, with sales down 46% year-over-year.
• Gross margin contracted by 560 basis points compared to the prior year due to product mix and lower volume.
• Net earnings decreased significantly year-over-year, from $2.793 million to $0.230 million.
• The company has lowered its full-year revenue guidance due to ongoing market conditions.
• Operating income decreased by 90% year-over-year.

Risks

• The semiconductor market weakness is expected to persist, impacting future revenue.
• The company faces challenges in converting backlog to sales and shipping products in a timely manner.
• Macroeconomic conditions and fluctuations in foreign currency exchange rates could affect financial results.
• The company's ability to manage supply chain challenges remains a risk.
• There is a risk that the company may not fully realize the benefits of the Alfamation acquisition.

Future Outlook

The company expects third-quarter revenue to be slightly lower than the second quarter, with a slight improvement in gross margin. Full-year 2024 revenue is now expected to be between $128 million and $133 million, with a gross margin of 42% to 43%.

Management Comments

• Nick Grant, President and CEO, stated that the company is facing challenging market headwinds that appear to be more persistent than anticipated.
• He noted that the addition of Alfamation contributed $9.7 million in revenue and that the integration is progressing well.
• He also mentioned that the company is taking actions to reduce costs and better align the businesses with current order levels.
• Management believes the industry in the near term has sufficient capacity for silicon carbide production.

Industry Context

The report highlights the ongoing weakness in the semiconductor industry, particularly in the front-end market, which is impacting inTEST's sales. The company's diversification strategy and acquisition of Alfamation are attempts to mitigate this downturn. The stabilization of the back-end semi market is a positive sign, but the overall outlook remains cautious.

Comparison to Industry Standards

• The 4% revenue growth is below the average growth rate for the broader technology sector, which has seen stronger growth in other areas.
• The 46% decline in semiconductor sales is worse than the average decline seen by many semiconductor equipment manufacturers, indicating a more severe impact on inTEST.
• Companies like Teradyne and Advantest, which also serve the semiconductor test market, have reported varying results, but inTEST's decline in this sector is more pronounced.
• The acquisition of Alfamation is a strategic move similar to those made by other companies to diversify their revenue streams and reduce reliance on a single market.
• The cost-cutting measures are in line with industry trends as companies adjust to the current economic environment.

Stakeholder Impact

• Shareholders will be concerned about the reduced profitability and lowered guidance.
• Employees may be affected by the cost reduction measures.
• Customers in the semiconductor market may experience delays or changes in product availability.
• Suppliers may see a decrease in orders due to the company's reduced outlook.

Next Steps

• The company will continue to focus on integrating Alfamation and realizing synergies.
• The company will continue to implement cost reduction measures.
• The company will monitor market conditions and adjust its strategy as needed.
• The company will host a conference call to discuss the results and outlook.

Key Dates

Keywords

inTEST Corporation, Alfamation, semiconductor, revenue growth, acquisition, financial results, cost reduction, market diversification, orders, backlog